Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thrombocythemia, Essential × talazoparib × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 4 Advanced Solid Tumors 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 mCRPC 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Fanconi Anemia, Complementation Group D1 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Adenocarcinoma 1 Advanced Solid Tumor 1 Advanced Ovarian Cancer 1

Interventions

fludarabine phosphate 15 Whole-Body Irradiation 9 Peripheral Blood Stem Cell Transplantation 9 Mycophenolic Acid 9 Cyclophosphamide 8 Busulfan 8 Tacrolimus 7 Cyclosporine 5 fludarabine 4 Methotrexate 4 Antilymphocyte Serum 4 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 ruxolitinib 2 peginterferon alfa-2a 2 givinostat hydrochloride 2 givinostat 2 Radiotherapy 2 Melphalan 2 Etoposide 2 Carboplatin 2 veliparib 1 thymoglobulin 1 sonidegib 1 pomalidomide 1 merphos 1 bomedemstat 1 anagrelide 1 Transplantation 1 Topotecan 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡